Home / News / India News / Article /
Serum Institute gets nod to send Covid-19 vaccines to Nepal, Bangladesh, Myanmar, bulk to AstraZeneca: Reports
Updated On: 07 October, 2021 09:08 PM IST | New Delhi | PTI
The Pune-based pharma company SII has also been allowed to supply bulk Covishield vaccine, which is equivalent to around 3 crore doses, to AstraZeneca in the UK

This picture has been used for representational purpose
The government has permitted Serum Institute of India (SII) to export 10 lakh Covishield doses each to Nepal, Myanmar and Bangladesh, while Bharat Biotech will provide Iran with 10 lakh doses of Covaxin under the 'Vaccine Maitri' programme in October, official sources said on Thursday.
The Pune-based pharma company SII has also been allowed to supply bulk Covishield vaccine, which is equivalent to around 3 crore doses, to AstraZeneca in the UK, they told PTI.
How do you like the new new mid-day.com experience? Share your feedback and help us improve.

